Nanomedicine Aims New Treatments at Cancer and Dangerous Wounds

Working on a very small scale lets scientists give drugs abilities denied to larger molecules

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


A molecule of DNA, holding its blueprint for life, is about 2.5 billionths of a meter in diameter. Scientists now have the ability to push and pull and build molecules of that size, as well as to create devices that sense them with unprecedented precision. These skills, gained through painstaking work during the past decade, are leading to new medicines and ways of diagnosing disease. In this special report, Scientific American examines what nanomedicine is bringing us now, what is coming soon and what the future will likely hold.

Right now chemotherapy is a major focus, and drugs that can slip into tumors because of their fine-grained construction are showing success where other medications fail patients [see “Cancer Drugs Hit Their Mark,]. Diagnostic tests are also taking advantage of the small sizes, using probes of unusually shaped DNA that can detect cancer with remarkable accuracy. Next, in the near future, patients should be able to use smart bandages made with nano-sized molecules that enhance the healing of severe wounds—or that signal doctors when healing is not happening [see “A Smarter Bandage”]. Further out in time, researchers hope to attach tiny molecular motors to drugs, driving them through the bloodstream to their targets [see “Launch the Nanobots!”]. These are feats of nanoengineering, invisible to the eye, yet they could have an outsize effect on health.

Josh Fischman is senior editor for special projects at Scientific American and covers medicine, biology and science policy. He has written and edited about science and health for Discover, ScienceEarth and U.S. News & World Report. Follow Fischman on Bluesky @jfischman.bsky.social

More by Josh Fischman
Scientific American Magazine Vol 312 Issue 4This article was published with the title “Small Wonders” in Scientific American Magazine Vol. 312 No. 4 (), p. 42
doi:10.1038/scientificamerican0415-42

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe